Cargando…

Physical activity for the prevention and treatment of sarcopenic obesity

Detalles Bibliográficos
Autores principales:	Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476845/ https://www.ncbi.nlm.nih.gov/pubmed/28631416 http://dx.doi.org/10.1002/jcsm.12216

Ejemplares similares

Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?
por: Ishida, Junichi, et al.
Publicado: (2017)

Is cardiac wasting accompanied by skeletal muscle loss in breast cancer patients receiving anticancer treatment?
por: Ishida, Junichi, et al.
Publicado: (2017)

Considering technique of assessment and method for normalizing skeletal muscle mass
por: Saitoh, Masakazu, et al.
Publicado: (2017)

Concern regarding quality and quality of muscle
por: Saitoh, Masakazu, et al.
Publicado: (2015)

The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: Skeletal muscle mass is associated with severe dysphagia in cancer patients
por: Saitoh, Masakazu, et al.
Publicado: (2016)

Growth differentiation factor‐15 as a prognostic biomarker in cancer patients
por: Ishida, Junichi, et al.
Publicado: (2016)

Clinical perspective for wasting in diaphragm, an ever‐trained muscle
por: Konishi, Masaaki, et al.
Publicado: (2016)

Sarcopenic obesity: time to target the phenotypes
por: Perna, Simone, et al.
Publicado: (2019)

Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
por: Ishida, Junichi, et al.
Publicado: (2015)

Irisin – a myokine potentially bridging muscle and fat tissue in cachexia
por: Konishi, Masaaki, et al.
Publicado: (2015)

Sarcopenic Obesity: An Emerging Public Health Problem, But an Answer Appears to Be Available
por: Machado, Marco
Publicado: (2022)

Prevention and Treatment of Sarcopenic Obesity in Women
por: Petroni, Maria L., et al.
Publicado: (2019)

Comment on “Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects”
por: Kuvačić, Goran, et al.
Publicado: (2017)

Novel mechanism of ghrelin therapy for cachexia
por: Hatanaka, Michiyoshi, et al.
Publicado: (2015)

Response to: Comment on “Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects”
por: Emerenziani, Gian Pietro, et al.
Publicado: (2017)

Comment #2 on “Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects”
por: Kuvačić, Goran, et al.
Publicado: (2018)

Response to Letter to the Editor, “Sarcopenic Obesity: An Emerging Public Health Problem, But an Answer Appears to Be Available”
por: Ji, Tong, et al.
Publicado: (2022)

Response to: Comment #2 on “Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects”
por: Emerenziani, Gian Pietro, et al.
Publicado: (2018)

Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain)
por: Hernández-Martínez, Paula, et al.
Publicado: (2022)

The Relevance of Diet, Physical Activity, Exercise, and Persuasive Technology in the Prevention and Treatment of Sarcopenic Obesity in Older Adults
por: Schoufour, Josje D., et al.
Publicado: (2021)

Author’s Reply: The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases
por: Runkel, Mira
Publicado: (2021)

Physical activity and sarcopenic obesity: definition, assessment, prevalence and mechanism
por: Lee, Duck-chul, et al.
Publicado: (2016)

Sarcopenia and Sarcopenic Obesity
por: Choi, Kyung Mook
Publicado: (2013)

Sarcopenia and sarcopenic obesity
por: Choi, Kyung Mook
Publicado: (2016)

Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
por: Wang, Mina, et al.
Publicado: (2020)

Recent Advances in Nutraceuticals for the Treatment of Sarcopenic Obesity
por: Kim, Young-Chan, et al.
Publicado: (2023)

Sarcopenic obesity and cognitive performance
por: Tolea, Magdalena I, et al.
Publicado: (2018)

Sarcopenic Obesity and Endocrinal Adaptation with Age
por: Sakuma, Kunihiro, et al.
Publicado: (2013)

Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy
por: Vera, Kathryn, et al.
Publicado: (2020)

CONTROVERSIES AND CHALLENGES IN DEFINING SARCOPENIC OBESITY
por: Batsis, John A
Publicado: (2019)

The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity?
por: Ilyas, Zahra, et al.
Publicado: (2022)

Editorial: Sarcopenic Obesity: Mechanisms and Countermeasures
por: Murton, Andrew J., et al.
Publicado: (2022)

Impact of sarcopenic obesity on functional outcomes
por: Shimizu, Akio, et al.
Publicado: (2023)

Editorial: (Osteo)Sarcopenia & sarcopenic obesity
por: Masiero, Stefano, et al.
Publicado: (2023)

Caloric restriction and aerobic exercise in sarcopenic and non‐sarcopenic obese women: an observational and retrospective study
por: Barbat‐Artigas, Sébastien, et al.
Publicado: (2015)

GABA Prevents Age-Related Sarcopenic Obesity in Mice with High-Fat-Diet-Induced Obesity
por: Jin, Heegu, et al.
Publicado: (2023)

Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines
por: Bilski, Jan, et al.
Publicado: (2022)

Exercise and physical performance in older adults with sarcopenic obesity: A systematic review
por: Ghiotto, Laura, et al.
Publicado: (2022)

The pandemic of childhood obesity: Challenges and possibilities from physical activity
por: Almonacid-Fierro, Alejandro, et al.
Publicado: (2022)

Sarcopenia and Sarcopenic Obesity in Patients with Muscular Dystrophy
por: Merlini, Luciano, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_em9ah96atel6jdbp7jg70pqjvq